2013-05-22 Jaarsveld, M.T.M. van

MicroRNAs and the DNA damage response: Relevance for cancer and anticancer therapy

Erasmus MC: University Medical Center Rotterdam

2012-10-03 Straetemans, G.C.M.

Towards clinical TCR gene therapy: tumor models and receptors

Erasmus MC: University Medical Center Rotterdam

2012-04-25 Eechoute, K.

Towards a pharmacologically guided individualization of imatinib and sunitnib therapy

Erasmus MC: University Medical Center Rotterdam

2012-04-25 Eechoute, K.

Towards a pharmacologically guided individualization of imatinib and sunitnib therapy

Erasmus MC: University Medical Center Rotterdam

2011-06-17 Bol, J.M. van der

Personalized Irinotecan Treatment: the patient matters

Erasmus MC: University Medical Center Rotterdam

2011-02-04 Konings, I.R.H.M.

Early clinical cancer trials: Proof of concept and beyond

Erasmus MC: University Medical Center Rotterdam Internal Medicine

2010-06-29 Pouw, N.M.C.

Towards effective TCR gene therapy: preclinical requirements

Erasmus MC: University Medical Center Rotterdam

2008-09-12 Meerten, E. van

Chemotherapy and Chemoradiotherapy Studies in Oesophageal Cancer

Erasmus MC: University Medical Center Rotterdam

2008-04-18 Gardner, E.R.

Factors Affecting Pharmacokinetic Variability of Imatinib Mesylate (Gleevec, STI-571)

Erasmus MC: University Medical Center Rotterdam

2006-12-14 Engels, F.K.

Pharmacokinetic Optimization of Docetaxel Dosing

Erasmus MC: University Medical Center Rotterdam Pharmacy